You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Prevalence rates of MDROs divided by screening strategy (non-overlapping Cis marked with *)

From: Epidemiology of multidrug resistant bacterial organisms and Clostridium difficile in German hospitals in 2014: Results from a nationwide one-day point prevalence of 329 German hospitals

Screening for MDRO Screening No screening
Number of hospitals Mean prevalence [95 % CI] Number of hospitals Mean prevalence [95 % CI]
MRSA MRSA 324 1.64 [1.46 – 1.82] 5 0.89 [-0.95 – 2.72]  
- MRSA (all universal) 22 2.49 [1.59 – 3.40]
- MRSA (risk based – KRINKO) 261 1.59 [1.39 – 1.79]
- MRSA (risk based - in-house regime) 10 1.65 [0.83 – 2.47]
- not reported   31 1.55 [0.86 – 2.24]
ESBL 3MRGN-EC 72 1.27 [0.83 – 1.71]* 257 0.60 [0.46 – 0.73] *
3MRGN-KS 0.40 [0.14 – 0.66] 0.17 [0.12 – 0.22]  
3MRGN-ES 0.24 [0.03 – 0.45] 0.06 [0.04 – 0.09]  
3MRGN-AB 0.01 [-0.01 – 0.03] 0.02 [0.00 – 0.04]  
3MRGN-PS 0.52 [0.04 – 0.99] 0.12 [0.08 – 0.16]  
VRE VRE 69 0.70 [0.17 – 1.23] 260 0.13 [0.08 – 0.18]  
4MRGN 4MRGN-EC 126 0.01 [-0.00 – 0.03] 203 0.01 [-0.01 – 0.03]  
4MRGN-KS 0.09 [-0.01 – 0.19]** 0.00 [-0.00 – 0.01] **
4MRGN-ES 0.02 [0.00 – 0.04] 0.00 [-0.00 – 0.01]  
4MRGN-AB 0.03 [0.00 – 0.06] 0.02 [0.00 – 0.03]  
4MRGN-PS 0.34 [0.05 – 0.63] 0.07 [0.03 – 0.10]  
  1. *p < 0,001; **p = 0,068